SHARP evaluated the effects of solriamfetol on cognitive function in patients with cognitive impairment associated with obstructive sleep apnea (OSA)and excessive daytime sleepiness (EDS).
Posters
Posters
This longitudinal study evaluated the impact of sleep disturbances, including hypersomnolence, on the progress of major depressive disorder (MDD) over a 3-year period.